4.8 Article

Accessibility of Different Histone H3-Binding Domains of UHRF1 Is Allosterically Regulated by Phosphatidylinositol 5-Phosphate

期刊

MOLECULAR CELL
卷 54, 期 6, 页码 905-919

出版社

CELL PRESS
DOI: 10.1016/j.molcel.2014.04.004

关键词

-

资金

  1. EMBO long-term fellowship
  2. Marie Curie Fellowship
  3. Max Planck Society
  4. German Research Foundation (DFG) [FI 1513/2-1, SCHW 1163/3-1]
  5. Cancer Research UK
  6. Natural Sciences and Engineering Research Council of Canada [372475-10]
  7. AbbVie
  8. Boehringer Ingelheim
  9. Canada Foundation for Innovation
  10. Canadian Institutes for Health Research
  11. Genome Canada through the Ontario Genomics Institute [OGI-055]
  12. GlaxoSmithKline
  13. Janssen
  14. Lilly Canada
  15. Novartis Research Foundation
  16. Ontario Ministry Research and Innovation
  17. Pfizer
  18. Takeda
  19. Wellcome Trust [092809/Z/10/Z]

向作者/读者索取更多资源

UHRF1 is a multidomain protein crucially linking histone H3 modification states and DNA methylation. While the interaction properties of its specific domains are well characterized, little is known about the regulation of these functionalities. We show that UHRF1 exists in distinct active states, binding either unmodified H3 or the H3 lysine 9 trimethylation (H3K9me3) modification. A polybasic region (PBR) in the C terminus blocks interaction of a tandem tudor domain (TTD) with H3K9me3 by occupying an essential peptide-binding groove. In this state the plant homeodomain (PHD) mediates interaction with the extreme N terminus of the unmodified H3 tail. Binding of the phosphatidylinositol phosphate PI5P to the PBR of UHRF1 results in a conformational rearrangement of the domains, allowing the TTD to bind H3K9me3. Our results define an allosteric mechanism controlling heterochromatin association of an essential regulatory protein of epigenetic states and identify a functional role for enigmatic nuclear phosphatidylinositol phosphates.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据